All

API

FDF

Price

Services

Excipients

Enquiries

Find

Active Pharmaceutical Ingredients
Finished Drug Formulations
Price
Excipients
Services
Marketplace

Market Place

Post Enquiry

Grow Your Pharma Business Digitally

Scorr-Insert

X

Find Clinical Drug Development Pipelines & Deals | PipelineProspector

A collaboration with SCORR Marketing

All Data

Filters

refresh

×

FILTER DATA :

News Type

Company

Product Type

Deal Size

Upfront Payment

refresh

Product Type

Companies

Kerecis

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

ICELAND Iceland

Post An Enquiry

BIO International Convention

Participation Not Confirmed

Update your events

Clinical Trial Evaluating Kerecis Omega3 Viruxide Spray for the Treatment of COVID-19 Patient

Contact the Supplier

Lead Product(s): Omega3 Viruxide

Therapeutic Area: Infections and Infectious Diseases

Highest Development Status: Undisclosed Product Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable April 09, 2020

Details:

The Omega3 Viruxide system, which is used in several Kerecis products, contains patented fatty acids, which decrease viral load and thereby lessen the symptoms of an infection.